Pure Global

ASSERACHROM® HPIA - India CDSCO Medical Device Registration

ASSERACHROM® HPIA is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2020/001026_f2cd6f247a8c71fa94a297cc803f1cf8_299d1a5381c1e484f651be1e1786ff2b. This device is marketed under the brand name Liatest AT III. The license holder is Syndicate Diagnostics Pvt. Ltd., and it is classified as Device Class Class C. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class C
ASSERACHROM® HPIA
UID: IMP/IVD/2020/001026_f2cd6f247a8c71fa94a297cc803f1cf8_299d1a5381c1e484f651be1e1786ff2b

Brand Name

Liatest AT III

Device Class

Class C

Approving Authority

CDSCO

Product Information

The Asserachrom® HPIA kit is intended for the qualitative detection in plasma or serum of the anti-heparin-platelet factor 4 (Liatest AT III) antibodies generated during the type II heparin-induced thrombocytopenias (Liatest AT III) by ELISA (Liatest AT III)

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing